Artivion (AORT) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.72% |
| Dec 31, 2025 | 135.90% |
| Sep 30, 2025 | 29.82% |
| Jun 30, 2025 | 22.25% |
| Mar 31, 2025 | 22.36% |
| Dec 31, 2024 | -28.05% |
| Sep 30, 2024 | -5.00% |
| Jun 30, 2024 | -23.61% |
| Mar 31, 2024 | 57.68% |
| Dec 31, 2023 | 37.13% |
| Sep 30, 2023 | -45.26% |
| Jun 30, 2023 | -81.74% |
| Mar 31, 2023 | -5.25% |
| Dec 31, 2022 | 19.54% |
| Sep 30, 2022 | -259.29% |
| Jun 30, 2022 | -22.84% |
| Mar 31, 2022 | -27.68% |
| Dec 31, 2021 | -44.41% |
| Sep 30, 2021 | 10.92% |
| Jun 30, 2021 | -20.73% |
| Mar 31, 2021 | -22.36% |
| Dec 31, 2020 | 38.94% |
| Sep 30, 2020 | -28.20% |
| Jun 30, 2020 | -98.36% |
| Mar 31, 2020 | -35.62% |
| Dec 31, 2019 | -37.79% |
| Sep 30, 2019 | -18.50% |
| Jun 30, 2019 | 2.73% |
| Mar 31, 2019 | -24.15% |
| Dec 31, 2018 | -19.80% |
| Sep 30, 2018 | -14.57% |
| Jun 30, 2018 | -15.43% |
| Mar 31, 2018 | -33.68% |
| Dec 31, 2017 | 4.68% |
| Sep 30, 2017 | -61.92% |
| Jun 30, 2017 | -5.87% |
| Mar 31, 2017 | 1.98% |
| Dec 31, 2016 | 5.60% |
| Sep 30, 2016 | 15.63% |
| Jun 30, 2016 | 0.45% |
| Mar 31, 2016 | 19.03% |
| Dec 31, 2015 | -18.61% |
| Sep 30, 2015 | 21.27% |
| Jun 30, 2015 | -49.54% |